A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

The cost of medication was too high for thousands of CF sufferers around the world. Now a Bangladeshi company is making a generic version that will change lives ...

Interim data from Phase 1 with single and multiple ascending doses show no safety signals and a generally favorable tolerability profile of ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

Scottish VTuber, Dizzy Illy, died after battling cystic fibrosis. Dizzy has been public about her struggles with cystic ...

After certain kinds of injuries or wounds — think heart attacks, burns and tendon tears, among others — scar tissue can form ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...

Study met its primary endpoint demonstrating safety and tolerability of CMTX-101 in people with cystic fibrosisCMTX-101 ...

Headquartered in Westworks, White City Place, London, UK. Investors include Netherton Investments (a fund investing on behalf of Mike Platt) and Dompé farmaceutici S.P.A. For more information, visit ...